During the COVID-19 pandemic, biobank Genomics England (GEL) launched an initiative with the UK government to deliver a cohort to eight leading pharmaceutical companies -- as well as research organizations -- to fuel vaccine, treatment, and early-detection research. The cohort included sequenced genomes from 20,000 COVID-19 patients with severe cases and 15,000 patients with mild cases, plus data from the GEL’s 100,000 Genomes Project.
Lifebit Biotech Ltd. uses Amazon Web Services (AWS) to power its federated research environment that enables collaborative research on disparate genomic datasets worldwide, maintains compliance with data privacy regulations, and processes more than 100 petabytes of project data. This whitepaper from AWS describes how Lifebit launched a research environment to study COVID-19 for GEL. Now, Lifebit CloudOS also powers GEL’s 100,000 Genomes Project on cancer and rare diseases.
Offered Free by: Amazon Web Services
See All Resources from: Amazon Web Services